1-year results of ADAPT-DES trial published in The Lancet

(Cardiovascular Research Foundation) Patients who receive a drug-eluting stent and demonstrate high platelet reactivity on clopidogrel are more likely to have blood clots form on the stent and to suffer a heart attack; however, these patients are less likely to develop bleeding complications. One-year results of the ADAPT-DES trial will be published online July 26, 2013, in The Lancet. The findings were first presented at last year's Transcatheter Cardiovascular Therapeutics annual scientific symposium.

http://www.eurekalert.org/pub_releases/2013-07/crf-oro072613.php

Source: EurekAlert! - Medicine and Health - July 26, 2013 Category: Global & Universal Source Type: news